Dianthus Therapeutics DNTH Share Based Compensation Expense — General And Administrative Expense

Other product segments

Similar metrics at other companies

TRA

TRAXExternal Expenses — General And Administrative Expense

$8.72M+127%

ANABExternal Expenses — General And Administrative Expense

$12.12M+119%

ANABInternal Expenses — General And Administrative Expense

$14.08M+63.9%

BEAMExternal General And Administrative Expenses — General And Administrative Expense

$13.37M+149%

SLDBExternal General And Administrative Expense — General And Administrative Expense

$6.33M+19.9%

SLDBInternal General And Administrative Expense — General And Administrative Expense

$4.73M+40.9%

FAQ

What is Dianthus Therapeutics's share based compensation expense — general and administrative expense?

Dianthus Therapeutics (DNTH) reported share based compensation expense — general and administrative expense of $5.75M in Q1 2026.

How has Dianthus Therapeutics's share based compensation expense — general and administrative expense changed year-over-year?

Dianthus Therapeutics's share based compensation expense — general and administrative expense increased by 102.6% year-over-year, from $2.84M to $5.75M.

What does share based compensation expense — general and administrative expense mean?

This metric captures the share-based compensation expense attributed to general and administrative functions, including executive management, legal, finance, and corporate operations. It quantifies the non-cash compensation cost associated with supporting the company's overall corporate infrastructure and overhead. Analyzing this figure provides insight into the cost of administrative talent and the impact of equity-based incentive programs on corporate operating expenses.